Sara Remuzgo-Martínez Selected Research

Sara Remuzgo-Martínez Research Topics

Disease

18	Rheumatoid Arthritis 08/2023 - 01/2015
11	Interstitial Lung Diseases (Interstitial Lung Disease) 08/2023 - 05/2020
11	Vasculitis (Vasculitides) 01/2023 - 03/2018
7	Autoimmune Diseases (Autoimmune Disease) 08/2023 - 03/2020
7	Giant Cell Arteritis (Horton Disease) 01/2023 - 03/2020
6	Axial Spondyloarthritis 01/2023 - 01/2018
6	Inflammation (Inflammations) 01/2022 - 12/2015
5	Idiopathic Pulmonary Fibrosis 01/2023 - 12/2020
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2022 - 12/2015
5	Atherosclerosis 01/2022 - 01/2015
4	Systemic Scleroderma (Systemic Sclerosis) 08/2023 - 05/2020
4	Obesity 01/2023 - 11/2020
4	Purpura 03/2018 - 04/2015
3	Ankylosing Spondylitis 01/2022 - 12/2015
3	Cardiovascular Diseases (Cardiovascular Disease) 05/2019 - 11/2016
3	IgA Vasculitis (Purpura, Schoenlein Henoch) 11/2017 - 01/2015
2	Coronary Artery Disease (Coronary Atherosclerosis) 12/2023 - 02/2016
2	Fibrosis (Cirrhosis) 04/2022 - 07/2021
2	Myositis (Idiopathic Inflammatory Myopathies) 01/2021 - 09/2020
2	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2017 - 11/2016
2	Infections 01/2016 - 08/2013
1	COVID-19 03/2024
1	Disease Progression 12/2023
1	Overweight 01/2023
1	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 01/2023
1	Necrosis 09/2022
1	Sacroiliitis 01/2022
1	Muscular Diseases (Myopathy) 01/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022
1	Hypothyroidism 01/2022
1	Idiopathic Interstitial Pneumonias 04/2021
1	Arthritis (Polyarthritis) 01/2021
1	Insulin Resistance 05/2019
1	Myocardial Ischemia (Ischemic Heart Diseases) 12/2016

Drug/Important Bio-Agent (IBA)

16	Biomarkers (Surrogate Marker)IBA 03/2024 - 12/2015
8	Immunoglobulin A (IgA)IBA 09/2022 - 11/2017
6	CytokinesIBA 01/2023 - 08/2013
5	AdipokinesIBA 01/2023 - 11/2016
5	HLA-DRB1 Chains (HLA DRB1)IBA 10/2021 - 01/2015
3	AdiponectinIBA 01/2023 - 11/2016
3	Interleukin-6 (Interleukin 6)IBA 01/2023 - 08/2013
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2022 - 04/2021
3	HLA-B Antigens (HLA-B)IBA 10/2021 - 04/2015
3	Ligases (Synthetase)IBA 01/2021 - 05/2020
3	Rheumatoid FactorIBA 11/2020 - 01/2020
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2019 - 11/2016
3	OsteoprotegerinIBA 03/2018 - 11/2016
2	Genetic Markers (Genetic Marker)IBA 12/2023 - 05/2016
2	E-SelectinIBA 08/2023 - 12/2017
2	LeptinIBA 01/2023 - 11/2020
2	HLA-DRB1*04:01 antigenIBA 01/2023 - 03/2021
2	tocilizumab (atlizumab)FDA Link 09/2022 - 05/2019
2	Antirheumatic Agents (DMARD)IBA 09/2022 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 04/2022 - 01/2020
2	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2022 - 11/2016
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2022 - 12/2017
2	erucylphosphocholineIBA 07/2021 - 12/2020
2	AutoantibodiesIBA 01/2021 - 05/2020
2	Interleukin-33IBA 01/2021 - 01/2015
2	InterleukinsIBA 03/2020 - 05/2019
2	Messenger RNA (mRNA)IBA 01/2020 - 12/2016
2	ImmunosorbentsIBA 03/2018 - 01/2018
2	EnzymesIBA 03/2018 - 01/2018
2	C-Reactive ProteinIBA 01/2018 - 01/2016
2	Adalimumab (Humira)FDA Link 12/2017 - 11/2016
2	CSK Tyrosine-Protein KinaseIBA 01/2017 - 10/2015
2	Protein Tyrosine PhosphatasesIBA 01/2017 - 10/2015
1	InflammasomesIBA 03/2024
1	Interleukin-18 (Interleukin 18)IBA 03/2024
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 08/2023
1	Endothelin-1 (Endothelin 1)IBA 01/2023
1	Interferon-gamma (Interferon, gamma)IBA 01/2023
1	Tumor Necrosis Factor InhibitorsIBA 01/2023
1	Vitamin D FDA LinkGeneric 01/2022
1	Oxidoreductases (Dehydrogenase)IBA 01/2022
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2022
1	C-PeptideIBA 01/2022
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2022
1	Mucin-1 (CA 15-3 Antigen)IBA 11/2021
1	Rituximab (Mabthera)FDA Link 09/2020
1	Antinuclear AntibodiesIBA 05/2020
1	Anti-Citrullinated Protein AntibodiesIBA 01/2020
1	Insulin (Novolin)FDA Link 05/2019
1	Glucose (Dextrose)FDA LinkGeneric 05/2019
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 05/2019
1	Saline SolutionIBA 05/2019
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2018
1	LipidsIBA 01/2018
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2018
1	P-SelectinIBA 12/2017
1	SelectinsIBA 12/2017
1	LigandsIBA 12/2016
1	EpitopesIBA 11/2016
1	Monoclonal AntibodiesIBA 11/2016
1	Interleukin-1beta (Interleukin 1 beta)IBA 05/2016
1	Calcitriol Receptors (Calcitriol Receptor)IBA 02/2016

Therapy/Procedure

5	Therapeutics 05/2022 - 12/2015
1	Biological Therapy 09/2022
1	Lung Transplantation 05/2020
1	Intravenous Administration 05/2019